Literature DB >> 14513361

Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers.

Il-Jin Kim1, Jae-Hyun Park, Hio Chung Kang, Yong Shin, Hye-Won Park, Hye-Rin Park, Ja-Lok Ku, Seok-Byung Lim, Jae-Gahb Park.   

Abstract

Recently, BRAF mutations were found in a variety of human cancers. Interestingly, the most common of BRAF mutation (V599E) has not been identified in tumors with K-ras mutations. Whereas the majority of human cancer types has been screened for BRAF mutations, no detailed studies on gastric cancers have been investigated. Thus, we decided to investigate the incidence of BRAF mutations in gastric cancers, and the relationship between BRAF and K-ras mutations in such cancers. Three non-pathogenic BRAF polymorphisms and seven K-ras missense mutations were found in 66 gastric cancers and 16 gastric cancer cell lines. Although only 9% of our gastric cancer panels had K-ras mutations, the incidence of BRAF mutations was not high. Thus, BRAF mutations, which are present in a variety of other human cancers, do not seem to be involved in gastric cancer development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513361     DOI: 10.1007/s00439-003-1027-0

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  18 in total

1.  Mutation of BRAF is uncommon in AML FAB type M1 and M2.

Authors:  M L Smith; J Snaddon; M Neat; M Cambal-Parrales; R Arch; T A Lister; J Fitzgibbon
Journal:  Leukemia       Date:  2003-01       Impact factor: 11.528

2.  Germline mutations of the dpc4 gene in Korean juvenile polyposis patients.

Authors:  I J Kim; J L Ku; K A Yoon; S C Heo; S Y Jeong; H S Choi; K H Hong; S K Yang; J G Park
Journal:  Int J Cancer       Date:  2000-05-15       Impact factor: 7.396

3.  Annual Report of the Central Cancer Registry in Korea-1999: Based on Registered Data from 128 Hospitals.

Authors:  J M Bae; Y J Won; K W Jung; K A Suh; D H Ahn; J G Park
Journal:  Cancer Res Treat       Date:  2001-10       Impact factor: 4.679

4.  A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes.

Authors:  N Arber; E K Han; A Sgambato; G A Piazza; T M Delohery; M Begemann; C M Weghorst; N H Kim; R Pamukcu; D J Ahnen; J C Reed; I B Weinstein; P R Holt
Journal:  Gastroenterology       Date:  1997-12       Impact factor: 22.682

5.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

6.  High frequency of BRAF mutations in nevi.

Authors:  Pamela M Pollock; Ursula L Harper; Katherine S Hansen; Laura M Yudt; Mitchell Stark; Christiane M Robbins; Tracy Y Moses; Galen Hostetter; Urs Wagner; John Kakareka; Ghadi Salem; Tom Pohida; Peter Heenan; Paul Duray; Olli Kallioniemi; Nicholas K Hayward; Jeffrey M Trent; Paul S Meltzer
Journal:  Nat Genet       Date:  2002-11-25       Impact factor: 38.330

7.  Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases.

Authors:  K H Lee; J S Lee; C Suh; S W Kim; S B Kim; J H Lee; M S Lee; M Y Park; H S Sun; S H Kim
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

8.  Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.

Authors:  Harith Rajagopalan; Alberto Bardelli; Christoph Lengauer; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  BRAF and RAS mutations in human lung cancer and melanoma.

Authors:  Marcia S Brose; Patricia Volpe; Michael Feldman; Madhu Kumar; Irum Rishi; Renee Gerrero; Eugene Einhorn; Meenhard Herlyn; John Minna; Andrew Nicholson; Jack A Roth; Steven M Albelda; Helen Davies; Charles Cox; Graham Brignell; Philip Stephens; P Andrew Futreal; Richard Wooster; Michael R Stratton; Barbara L Weber
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

View more
  25 in total

1.  Distribution of some activating KRAS and BRAF mutations in Slovene patients with colorectal cancer.

Authors:  Alenka Ličar; Petra Cerkovnik; Srdjan Novaković
Journal:  Med Oncol       Date:  2010-07-20       Impact factor: 3.064

2.  Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?

Authors:  Hilda Wong; Thomas Yau
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

Review 3.  Advances of Molecular Targeted Therapy in Gastric Cancer.

Authors:  Bulent Cetin; Ozge Gumusay; Mustafa Cengiz; Ahmet Ozet
Journal:  J Gastrointest Cancer       Date:  2016-06

4.  Targeted therapy in the management of advanced gastric cancer: are we making progress in the era of personalized medicine?

Authors:  Hilda Wong; Thomas Yau
Journal:  Oncologist       Date:  2012-02-14

Review 5.  Role of the tumor microenvironment in the pathogenesis of gastric carcinoma.

Authors:  Hye Won Chung; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

6.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

7.  Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.

Authors:  I-J Kim; J-L Ku; H C Kang; J-H Park; K-A Yoon; Y Shin; H-W Park; S G Jang; S-K Lim; S Y Han; Y-K Shin; M R Lee; S-Y Jeong; H-R Shin; J S Lee; W-H Kim; J-G Park
Journal:  Hum Genet       Date:  2004-09-24       Impact factor: 4.132

8.  K-ras mutation, HPV infection and smoking or alcohol abuse positively correlate with esophageal squamous carcinoma.

Authors:  Ioannis D Lyronis; Stavroula Baritaki; Ioannis Bizakis; Elias Krambovitis; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2008-07-01       Impact factor: 3.201

9.  A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth.

Authors:  Hiroaki Mita; Minoru Toyota; Fumio Aoki; Hirofumi Akashi; Reo Maruyama; Yasushi Sasaki; Hiromu Suzuki; Masashi Idogawa; Lisa Kashima; Kazuyoshi Yanagihara; Masahiro Fujita; Masao Hosokawa; Masanobu Kusano; Sorin Vasile Sabau; Haruyuki Tatsumi; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  BMC Cancer       Date:  2009-06-23       Impact factor: 4.430

10.  Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Authors:  F Lordick; B Luber; S Lorenzen; S Hegewisch-Becker; G Folprecht; E Wöll; T Decker; E Endlicher; N Röthling; T Schuster; G Keller; F Fend; C Peschel
Journal:  Br J Cancer       Date:  2010-01-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.